Literature DB >> 2145593

Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

N A Darmani1, B R Martin, U Pandey, R A Glennon.   

Abstract

To investigate the possible functional relationship between 5-HT1 and 5-HT2 receptors, we studied the effects of a nonselective 5-HT agonist (5-MeO DMT), a 5-HT1A-selective (8-OH-DPAT) and a 5-HT1B/5-HT1C-selective (TFMPP) agonist on the head-twitch behavior induced by the putative 5-HT2-selective receptor agonist (+/-)-DOI. In the mouse (+/-)-DOI produced the head-twitch response in a dose-dependent manner and (-)-DOI was twice as potent as the (+) isomer. Selective 5-HT2 antagonists, ketanserin and spiperone, dose-dependently inhibited the (+/-)-DOI-induced head-twitch response. The nonselective and the 5-HT1A-selective agonists also dose-dependently reduced the behavior, whereas 5-HT1B/5-HT1C-selective agonist (TFMPP) failed to affect the (+/-)-DOI-induced response. Taken together with previously published literature data, we propose a 5-HT1A inhibitory action on the 5-HT2 receptor-mediated response when induced by its selective agonist (+/-)-DOI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145593     DOI: 10.1016/0091-3057(90)90098-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  52 in total

1.  Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.

Authors:  Y Zhang; D D'Souza; D K Raap; F Garcia; G Battaglia; N A Muma; L D Van de Kar
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 2.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

Review 3.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

4.  Locomotor-activated neurons of the cat. I. Serotonergic innervation and co-localization of 5-HT7, 5-HT2A, and 5-HT1A receptors in the thoraco-lumbar spinal cord.

Authors:  Brian R Noga; Dawn M G Johnson; Mirta I Riesgo; Alberto Pinzon
Journal:  J Neurophysiol       Date:  2009-07-01       Impact factor: 2.714

5.  YKP1447, A Novel Potential Atypical Antipsychotic Agent.

Authors:  Seon Min Dong; Yong Gil Kim; Joon Heo; Mi Kyung Ji; Jeong Woo Cho; Byong Sung Kwak
Journal:  Korean J Physiol Pharmacol       Date:  2009-04-30       Impact factor: 2.016

6.  Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment.

Authors:  P Kaur; S Ahlenius
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

Authors:  Catharine A Winstanley; Yogita Chudasama; Jeffrey W Dalley; David E H Theobald; Jeffrey C Glennon; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2003-04-02       Impact factor: 4.530

8.  Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

9.  Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.

Authors:  Efrain E Garcia; Randy L Smith; Elaine Sanders-Bush
Journal:  Neuropharmacology       Date:  2007-04-04       Impact factor: 5.250

10.  5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.

Authors:  Adam L Halberstadt; Iris van der Heijden; Michael A Ruderman; Victoria B Risbrough; Jay A Gingrich; Mark A Geyer; Susan B Powell
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.